01 5MAYNE PHARMA
02 1SEBELA IRELAND LTD
01 18486456
02 18921374
03 19272046
04 19713642
05 110463740
06 110806792
01 6Blank
01 5Y
02 1Blank
01 12028-10-03
02 52033-06-21
Patent Expiration Date : 2033-06-21
US Patent Number : 10463740
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208901
Patent Use Code : U-2453
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-06-21
Patent Expiration Date : 2033-06-21
US Patent Number : 9713642
Drug Substance Claim :
Drug Product Claim :
Application Number : 208901
Patent Use Code : U-2453
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-06-21
Patent Expiration Date : 2033-06-21
US Patent Number : 10806792
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208901
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-06-21
Patent Expiration Date : 2033-06-21
US Patent Number : 8921374
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208901
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-06-21
Patent Expiration Date : 2033-06-21
US Patent Number : 9272046
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208901
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-06-21
Patent Expiration Date : 2028-10-03
US Patent Number : 8486456
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22484
Patent Use Code : U-1054
Delist Requested :
Patent Use Description : ONYCHOMYCOSIS OF THE T...
Patent Expiration Date : 2028-10-03
